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the utmost care. This means that issues, which are necessarily dealt with 
in a synoptical manner (and fluorescence compensation is certainly one 
of them) can be easily looked up for the curious beginner. 
All in all then, a good volume to give to your students and 
315 
technicians, but probably not your post-does. At its price, it should 
nevertheless be a welcome addition to any flow cytometry library, and 
with some improvement i  should definitely become a must. 
Peter Hokland 
From Genotype to Phenotype; Edited by SE. Humphries and S. Malcolm, BIOS Scientific Publishers Ltd.; Oxford, 1994; 290 pages. 
$99.00. ISBN l-872748-62-7. 
The editors state in the preface: “14 authors, each expert in their field, 
explore the problems of how the effect of different mutations - the 
‘genotype’ of the individual - are modulated to produce variability in 
the clinical symptoms - the ‘phenotype’ shown by the patient”. This 
statement and the title of the book are exciting, because the genotype/ 
phenotype relationship right now is the focus of many discussions about 
genetic diseases. The book covers a wide variety of diseases, which in 
the order of chapters are: Cystic fibrosis, Collagen diseases, Gauchers 
disease, Familial hypercholesterolernia, Charcot-Marie-Tooth disease, 
Wilms’ tumour, Myotonic dystrophy, Fragile X, Somatic mosaicism, 
Chimerism and X-inactivation, Mitochondrial DNA diseases, 
Diabetes, Coronary artery diseases, and gene therapy of dyslipidemias. 
This very diverse organisation of the book is both a strength and a 
weakness. The strength is that each disease and diseased gene is covered 
by researchers actually working in the field, assuring that data and 
conceptions are up to date, and that questions treated are relevant o 
other researchers in the field. For the clinical geneticist, reading this 
book is a nice way of being updated on a variety of diseases, in which 
molecular genetic research has opened new areas for diagnosis and 
predictions of clinical outcome. As a molecular geneticist it has also 
been a pleasure for me to get up-to-date information about diseases, 
of which I had only heard from colleagues and at conferences on 
genetics. However, this very broad selection of themes is also a 
weakness of the book. One can ask why this particular selection of 
articles has been collected. There is no natural relationship between the 
chapters. However, in all cases the molecular elucidation of the disease 
mechanisms resulted in a stage of knowledge, from which it is possible 
to answer some of the questions concerning genotype/phenotype 
relationships. 
informatively, and especially the chapter by Mark Hirst on Fragile X 
is exciting, with very good discussions about the dynamics and 
expansion of the CGG triplet within the FMRl (fragile X mental 
retardation) gene, the structure and expression of the gene, and the 
mechanism of the expansion. 
To comment on all themes is impossible. I will restrict myself to a 
few of the chapters representing the various types of diseases. 
The chapter written by Anne Soutar on Familial 
Hypercholesterolemia certainly broadens out the often narrow 
discussions in journal papers. Since I have some knowledge of the 
current state of discussions among researchers in Familial 
Hypercholesterolemia, I highly value the chapter. It has only recently 
been possible for researchers working on this disease to embark on the 
correlation between the site and type of mutations in the LDL-receptor 
gene and the clinical expression of the disease. Anne Soutar sums up 
very nicely the current knowledge, i.e. that for homozygous patients 
with LDL-receptor defects there seems to exist a correlation between 
the severity of the mutation and the severity of the disease, but that the 
clinical expression in heterozygous patients are much more - and to a 
large extent - governed by other factors, both genetical and 
environmental. This chapter is a delight to read. Steve Humphries, one 
of the editors, also provides a chapter on coronary artery disease, 
especially focused on the discussion about the variability gene concept, 
which is based on the hypothesis that some genes affect the level of a 
risk factor and others determine the variability. It is an interesting 
concept which can be applied to many other diseases, that are 
influenced by risk factors, such as susceptibility genes. Susceptibility 
genes are the main theme in the chapter on Diabetes. A good update 
is given for instance on the susceptibility role of certain HLA 
haplotypes. I cannot fully judge the originality of the information and 
discussion given by Hitman, Fennessy and Metcalfe, but the discussion 
is certainly interesting from a more general point of view as a model- 
study in polygenic and multifactorial diseases. 
One of the more exciting developments during the last few years has In conclusion, this book is a good initiative to substantiate the very 
been the elucidation of the dynamic mutations in Myotonic dystrophy difficult discussions about the genotype/phenotype r lationship, which 
and the Fragile-X syndrome, in which the disease-causing mutations in certain - perhaps in most -diseases is not only influenced by the type 
are expansions of trinucleotide repeats, the array length of which seems of mutation in the respective gene, but even more by susceptibility 
to account for the anticipation, i.e. the phenomenon that the disease factors, modifying genes, and environmental conditions. The theme will 
most often deteriorates from one generation to the next once it has explode and we are just waiting for the next book. 
occurred in a family. The authors have written these two chapters very Niels Gregersen 
